Flemingsberg Science celebrates ten years – follow the journey to today

This year marks the 10 year anniversary of the start of the Flemingsberg Science Foundation. The decade has seen a number of initiatives that have contributed to the development of Flemingsberg as a regional city center in southern Stockholm.

A new publication summarizes the ten-year journey made by the Flemingsberg Science Foundation during the years 2011-2021. Here, the foundation’s three periods of activity are described under the headings: More new knowledge-intensive companies, Collaboration for a strong campus and A living and open university city.

All periods are reflected through interviews with a number of people who in various forms have been active in the work. Among them is Matti Sällberg, professor at KI:
– Flemingsbergs Science had a central role in the establishment of Campus Flemingsberg as a concept and that it is now seen as a physical environment, says Matti Sällberg, professor and biomedical analyst at the Department of Laboratory Medicine at Karolinska Institutet.

In the publication, you can also follow the last ten years’ physical development of Flemingsberg and also get a glimpse of the future regional city center.

The publication “Flemingsberg Science 2011-2021” was presented in connection with the appointment of a new CEO of the foundation.

Press Start: The Game Hub in Flemingsberg – Finally!

On April 24th, after just two months of hard work, it was finally time for the kick-off for the game cluster Press Start. The initiative is led by Drivhuset, in close collaboration with Flemingsberg Science Foundation and Södertörn University's Innovation Station.

AlzeCure Pharma – a hope in the fight against Alzheimer’s

Neurological diseases and the pain area are struggling with great medical needs, including the lack of broad-spectrum drugs. Those are gaps in the market that AlzeCure Pharma wants to fill, and they are well on their way. They recently received a grant from the European Innovation Council (EIC) to finance a clinical phase 2 study of the drug candidate NeuroRestore ACD856 for Alzheimer’s disease.

Kick-off Cluster Engine Life Science Flemingsberg!

At the end of last year, the Flemingsberg Science Foundation was granted funding from the European Regional Development Fund (ERDF) for the project Cluster Engine Life Science Flemingsberg, which aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. Recently, it was time for the official launch – and what a grand launch it was!

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

CF_logo_neg
2021-11-08T18:19:56+01:00
Go to Top